Irenic Capital Management LP Increases Stock Holdings in Sotera Health Company $SHC

Irenic Capital Management LP raised its position in Sotera Health Company (NASDAQ:SHC) by 17.9% in the second quarter, according to its most recent disclosure with the SEC. The firm owned 5,141,822 shares of the company’s stock after acquiring an additional 782,474 shares during the period. Sotera Health makes up about 4.4% of Irenic Capital Management LP’s holdings, making the stock its 5th largest position. Irenic Capital Management LP’s holdings in Sotera Health were worth $91,267,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. IFP Advisors Inc lifted its holdings in shares of Sotera Health by 1,105.6% in the 4th quarter. IFP Advisors Inc now owns 1,495 shares of the company’s stock worth $26,000 after purchasing an additional 1,371 shares in the last quarter. Rothschild Investment LLC bought a new stake in Sotera Health during the 4th quarter valued at $27,000. Root Financial Partners LLC increased its stake in Sotera Health by 217.5% during the 1st quarter. Root Financial Partners LLC now owns 2,124 shares of the company’s stock valued at $30,000 after purchasing an additional 1,455 shares in the last quarter. Meeder Asset Management Inc. acquired a new position in Sotera Health during the second quarter worth $37,000. Finally, EverSource Wealth Advisors LLC raised its holdings in Sotera Health by 831.4% during the second quarter. EverSource Wealth Advisors LLC now owns 3,288 shares of the company’s stock worth $37,000 after buying an additional 2,935 shares during the last quarter. Institutional investors own 91.03% of the company’s stock.

Analyst Upgrades and Downgrades

SHC has been the subject of a number of analyst reports. Weiss Ratings upgraded shares of Sotera Health from a “hold (c)” rating to a “hold (c+)” rating in a report on Tuesday, August 11th. Wall Street Zen upgraded shares of Sotera Health from a “buy” rating to a “strong-buy” rating in a report on Saturday, August 29th. Barclays raised their price target on shares of Sotera Health from $19.00 to $22.00 and gave the company an “overweight” rating in a research report on Friday, August 7th. Citigroup boosted their price objective on Sotera Health from $23.00 to $25.00 and gave the stock a “buy” rating in a report on Friday, August 7th. Finally, UBS Group set a $19.00 price objective on Sotera Health in a research note on Wednesday, June 24th. Eight research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $21.50.

Insider Activity at Sotera Health

In related news, insider Michael P. Rutz sold 150,000 shares of the stock in a transaction that occurred on Friday, August 7th. The stock was sold at an average price of $18.84, for a total transaction of $2,826,000.00. Following the completion of the sale, the insider directly owned 334,279 shares of the company’s stock, valued at approximately $6,297,816.36. This trade represents a 30.97% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Chairman Michael B. Jr. Petras sold 850,000 shares of the stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $18.50, for a total value of $15,725,000.00. Following the sale, the chairman directly owned 3,969,393 shares of the company’s stock, valued at $73,433,770.50. The trade was a 17.64% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last ninety days, insiders sold 1,294,515 shares of company stock valued at $23,999,528. 15.36% of the stock is currently owned by corporate insiders.

Sotera Health Stock Down 0.7%

Sotera Health stock opened at $18.90 on Friday. Sotera Health Company has a fifty-two week low of $13.09 and a fifty-two week high of $19.85. The company has a debt-to-equity ratio of 3.33, a quick ratio of 2.55 and a current ratio of 2.80. The firm’s 50-day simple moving average is $18.35 and its 200 day simple moving average is $16.47. The stock has a market cap of $5.39 billion, a PE ratio of 33.16 and a beta of 1.77.

Sotera Health (NASDAQ:SHC) last posted its quarterly earnings data on Thursday, August 6th. The company reported $0.26 EPS for the quarter, beating the consensus estimate of $0.24 by $0.02. Sotera Health had a net margin of 13.44% and a return on equity of 40.12%. The firm had revenue of $321.38 million during the quarter, compared to analyst estimates of $309.70 million. During the same quarter last year, the business posted $0.20 EPS. The company’s revenue for the quarter was up 9.2% on a year-over-year basis. Sotera Health has set its FY 2026 guidance at 0.950-1.010 EPS. Research analysts predict that Sotera Health Company will post 0.86 EPS for the current fiscal year.

Sotera Health Company Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.